Allergo Journal最新文献

{"title":"IL-13-Antikörper hemmt die Typ-2-Inflammation bei AD","authors":"Kirsten Westphal","doi":"10.1007/s15007-025-6538-8","DOIUrl":"10.1007/s15007-025-6538-8","url":null,"abstract":"","PeriodicalId":7418,"journal":{"name":"Allergo Journal","volume":"34 5","pages":"64 - 64"},"PeriodicalIF":1.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145168235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Rückblick auf ein aktives Verbandshalbjahr","authors":"Redaktion Facharztmagazine","doi":"10.1007/s15007-025-6524-1","DOIUrl":"10.1007/s15007-025-6524-1","url":null,"abstract":"","PeriodicalId":7418,"journal":{"name":"Allergo Journal","volume":"34 5","pages":"66 - 67"},"PeriodicalIF":1.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145168236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"AeDA-Forschungspreis Young Researcher 2025","authors":"Redaktion Facharztmagazine","doi":"10.1007/s15007-025-6527-y","DOIUrl":"10.1007/s15007-025-6527-y","url":null,"abstract":"","PeriodicalId":7418,"journal":{"name":"Allergo Journal","volume":"34 5","pages":"72 - 72"},"PeriodicalIF":1.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145168237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Schweregradbeurteilung von Nahrungsmittelallergien nach DEFASE-Kriterien im Deutschen Gesundheitssystem (d-DEFASE)","authors":"Stefania Arasi,&nbsp; Lars Lange,&nbsp; Katharina Blümchen,&nbsp;Nora Knappe,&nbsp; Katja Nemat,&nbsp; Randolf Brehler,&nbsp; Stefani Röseler,&nbsp; Michael Gerstlauer,&nbsp; Jan Hagemann,&nbsp; Friederike Bärhold,&nbsp; Ingrid Casper,&nbsp;Philippe Eigenmann,&nbsp;Alessandro Fiocchi,&nbsp; Ludger Klimek,&nbsp; Christian Vogelberg","doi":"10.1007/s15007-025-6504-5","DOIUrl":"10.1007/s15007-025-6504-5","url":null,"abstract":"<p><b>Hintergrund:</b> Aktuell existiert in Deutschland kein einheitliches Bewertungssystem zur Definition und Einteilung des Schweregrades von Nahrungsmittelallergien (NMA). Nach Entwicklung der internationalen Einteilung „DEFASE“ („Definition of Food Allergy Severity“) wird dieses Bewertungssystem nun auch in Deutschland vorgestellt und seine Anwendbarkeit im deutschen Gesundheitssystem geprüft.</p><p><b>Methodik:</b> DEFASE wurde in einem zweistufigen Verfahren (Literaturrecherche und eDelphi-Verfahren) als Punktesystem zur Definition der Schwere von NMA erarbeitet. Es wurde ein internationaler Konsens für dieses Scoring-System erreicht. Das Scoring-System bietet ein Bewertungsraster, das den Schweregrad einer NMA unterstützend beurteilen kann. </p><p><b>Zitierweise:</b> Arasi S, Lange L, Blümchen K, Knappe N, Nemat K, Brehler R, Röseler S, Gerstlauer M, Hagemann J, Bärhold F, Casper I, Eigenmann P, Fiocchi A, Klimek L, Vogelberg C. Severity assessment of food allergies according to DEFASE criteria in the German healthcare system (d-DEFASE). A position paper of the Association of German Allergists (AeDA) and the Society for Pediatric Allergology and Environmental Medicine (GPA). Allergo J Int 2025;34:113-20</p><p>https://doi.org/10.1007/s40629-025-00334-y</p><p><b>Schlussfolgerungen:</b> Der DEFASE-Score ist die erste umfassende Einstufung des Schweregrades einer NMA, die nicht nur die Schwere einer einzelnen Reaktion, sondern das gesamte Krankheitsbild berücksichtigt. Wesentlich ist, dass hierfür ein internationaler Konsens über ein Scoring-System für NMA erreicht wurde, der als d-DEFASE nun auch in Deutschland eingesetzt werden kann. In Phase 3 soll das Bewertungssystem im Rahmen von Forschungsprojekten erprobt und in die klinische Praxis eingeführt werden.</p>","PeriodicalId":7418,"journal":{"name":"Allergo Journal","volume":"34 5","pages":"14 - 24"},"PeriodicalIF":1.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145168232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Selbstberichtete Weizensensitivität häufig - bestätigte Weizenallergie selten","authors":"Kathrin von Kieseritzky","doi":"10.1007/s15007-025-6535-y","DOIUrl":"10.1007/s15007-025-6535-y","url":null,"abstract":"","PeriodicalId":7418,"journal":{"name":"Allergo Journal","volume":"34 5","pages":"12 - 13"},"PeriodicalIF":1.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145160755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Epidemiologie der Nahrungsmittelallergie","authors":"Alisa Arens,&nbsp; Lars Lange,&nbsp;Kristina Stamos","doi":"10.1007/s15007-025-6515-2","DOIUrl":"10.1007/s15007-025-6515-2","url":null,"abstract":"<p>Nahrungsmittelallergien sind mit erheblichen psychosozialen Belastungen und Einschränkungen der Lebensqualität verbunden. Während Eltern oft von Nahrungsmittelallergien bei ihren Kindern berichten, zeigen Studien, dass die wahrgenommene Prävalenz häufig höher ist als die tatsächlich diagnostizierte. Epidemiologische Studien belegen eine weltweit steigende Prävalenz, mit deutlichen regionalen Unterschieden. In Europa schwankt die Selbstberichtprävalenz stark, von unter 1 % bis über 10 %, abhängig von Region, Alter und untersuchenden Lebensmitteln. In Nordamerika und Nordeuropa sind Erdnuss- und Hühnereiallergien häufiger, während in Asien Schalentier- und Fischallergien dominieren. Umweltfaktoren, ethnische Zugehörigkeit, genetische Prädisposition, Ernährungsgewohnheiten und sozioökonomische Bedingungen spielen eine wesentliche Rolle bei der Entstehung und Verteilung von Nahrungsmittelallergien. Diese Faktoren müssen bei der Entwicklung von Präventions- und Behandlungsstrategien berücksichtigt werden.</p><p><b>Zitierweise:</b> Arens A, Lange L, Stamos K. Epidemiology of food allergy. Allergo J Int 2025;34: 121-6</p><p>https://doi.org/10.1007/s15007-025-6515-2</p>","PeriodicalId":7418,"journal":{"name":"Allergo Journal","volume":"34 5","pages":"25 - 31"},"PeriodicalIF":1.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145168233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"IgE immunoadsorption: technical background, functionality, and first clinical experience","authors":"Lucia Lo Scalzo,&nbsp;Maddalena Sciannamea,&nbsp;Arianna Cafarotti,&nbsp;Lamia Dahdah,&nbsp; Ludger Klimek,&nbsp;Stefania Arasi MD PhD MSc","doi":"10.1007/s15007-025-6520-5","DOIUrl":"10.1007/s15007-025-6520-5","url":null,"abstract":"<p><b>Background:</b> The prevalence of allergic diseases has risen in the 21st century, drawing attention to specific therapeutic and preventive strategies. Due to the key role of immunoglobulin E (IgE) in the development of allergic reactions, IgE represents a key target treatment. In this scenario, IgE immunoadsorption (IgE-IA) has been investigated as a procedure that selectively removes circulating IgE antibodies from the bloodstream of patients with atopy.</p><p><b>Methods:</b> This narrative review aims to critically summarize the current insights regarding IgE-IA in the context of the management of allergic diseases, ranging from the rationale to the technical aspects, as well as the benefits and unmet needs.</p><p><b>Results:</b> IgE-IA might be a treatment strategy in wellselected patients with allergic diseases. IgE depletion through sessions of IgE-IA results in immediate clinical improvement and might be useful in acute situations when a rapid clinical response is required or when classic approaches are contraindicated or ineffective. Due to the reduced effectiveness over time, IgE-IA could be a valid first approach before starting another IgE depletion therapy, such as omalizumab, when its commencement would otherwise be contraindicated by too-high serum IgE levels.</p><p><b>Conclusion:</b> Overall, IgE-IA is safe and well tolerated; however, this procedure is currently difficult to implement in routine clinical practice because of costs, time demands, need for hospitalization, and the invasiveness of the procedure, with the associated risks related to the necessity of venous catheterization.</p><p><b>Cite this as</b> Lo Scalzo L, Sciannamea M, Cafarotti A, Dahdah L, Klimek L, Arasi S. IgE immunoadsorption: technical background, functionality, and first clinical experience. Allergo J Int 2025; 34:139-47</p><p><b>https://doi.org/10.1007/s40629-024-00311-x</b></p>","PeriodicalId":7418,"journal":{"name":"Allergo Journal","volume":"34 5","pages":"45 - 53"},"PeriodicalIF":1.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145168239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Therapeutische Ansätze bei Nahrungsmittelallergien","authors":"Nora Knappe,&nbsp; Katja Nemat,&nbsp; Christian Vogelberg","doi":"10.1007/s15007-025-6519-y","DOIUrl":"10.1007/s15007-025-6519-y","url":null,"abstract":"<p>Diese Arbeit gibt eine Übersicht über die verschiedenen Therapieoptionen bei Nahrungsmittelallergien, angefangen vom Verzehr stark erhitzter Lebensmittel, über Immuntherapien, Lebensmittel-Leitern bis zur medikamentösen Behandlung.</p><p><b>Zitierweise:</b> Knappe N, Nemat K, Vogelberg C. Therapeutic approaches to food allergies. Allergo J Int 2025;34:134-8</p><p>https://doi.org/10.1007/s15007-025-6519-y</p>","PeriodicalId":7418,"journal":{"name":"Allergo Journal","volume":"34 5","pages":"39 - 44"},"PeriodicalIF":1.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145169494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Anti-IgE-Antikörpertherapie bei Nahrungsmittelallergien","authors":"Kathrin von Kieseritzky","doi":"10.1007/s15007-025-6539-7","DOIUrl":"10.1007/s15007-025-6539-7","url":null,"abstract":"","PeriodicalId":7418,"journal":{"name":"Allergo Journal","volume":"34 5","pages":"10 - 10"},"PeriodicalIF":1.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145168230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Starkes Darmmikrobiom zur Ekzemprävention","authors":"Sabrina Kempe","doi":"10.1007/s15007-025-6513-4","DOIUrl":"10.1007/s15007-025-6513-4","url":null,"abstract":"","PeriodicalId":7418,"journal":{"name":"Allergo Journal","volume":"34 4","pages":"12 - 12"},"PeriodicalIF":1.0,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145165421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}